During the SAFC global media summit held in Chicago recently, In-PharmaTechnologist’s Gareth MacDonald caught up with SAFC Pharma Vice President Dave Feldker to talk about the company’s investment at its St. Louis, MO. and Irvine, Scotland sites in developing its liquid cell culture reagents in response to growing biomanufacturing industry demand. Feldker also discusses how this investment dovetails with other investment that SAFC has made recently, in particular in the expansion of its dry powder media manufacturing capabilities at its Lenexa, KS. site.
Check out the full video interview here
